There was a statistical trend indicating that increased use of SDP transfusions was associated with an increased likelihood of induction-related mortality (10.6% in patients given over 3 units of SDP vs. 1.5% in patients given 3 or less SDP units; p = 0.076).
← all excerpts
Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients.
2
—
—
The sentences
Use of RBC infusions, total platelet units given, and SDP units administered did not reach statistical significance.